|
1
|
Catalano V, Labianca R, Beretta GD, Gatta
G, de Braud F and Van Cutsem E: Gastric cancer. Gastric Rev Oncol
Hematol. 71:127–164. 2009. View Article : Google Scholar
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maruyama K: The most important prognostic
factors for gastric cancer patients: A study using univariate and
multivariate analyses. Scand J Gastroenterol. 22:63–68. 1987.
View Article : Google Scholar
|
|
5
|
Huang L, Wu RL and Xu AM:
Epithelial-mesenchymal transition in gastric cancer. Am J Transl
Res. 7:2141–2158. 2015.PubMed/NCBI
|
|
6
|
Turksen K and Troy TC: Junctions gone bad:
Claudins and loss of the barrier in cancer. Biochim Biophys Acta.
1816:73–79. 2011.PubMed/NCBI
|
|
7
|
Kwon MJ, Kim SH, Jeong HM, Jung HS, Kim
SS, Lee JE, Gye MC, Erkin OC, Koh SS, Choi YL, et al: Claudin-4
overexpression is associated with epigenetic derepression in
gastric carcinoma. Lab Invest. 91:1652–1667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zavala-Zendejas VE, Torres-Martinez AC,
Salas-Morales B, Fortoul TI, Montano LF and Rendon-Huerta EP:
Claudin-6, 7, or 9 overexpression in the human gastric
adenocarcinoma cell line AGS increases its invasiveness, migration,
and proliferation rate. Cancer Invest. 29:1–11. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sanada Y, Oue N, Mitani Y, Yoshida K,
Nakayama H and Yasui W: Down-regulation of the claudin-18 gene,
identified through serial analysis of gene expression data
analysis, in gastric cancer with an intestinal phenotype. J Pathol.
208:633–642. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu YL, Zhang S, Wang GR and Chen YP:
Expression transformation of claudin-1 in the process of gastric
adenocarcinoma invasion. World J Gastroenterol. 14:4943–4948. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang J, Zhang L, He C, Qu Y, Li J, Zhang
J, Du T, Chen X, Yu Y and Liu B: Claudin-1 enhances tumor
proliferation and metastasis by regulating cell anoikis in gastric
cancer. Oncotarget. 6:1652–1665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Satake S, Semba S, Matsuda Y, Usami Y,
Chiba H, Sawada N, Kasuga M and Yokozaki H: Cdx2 transcription
factor regulates claudin-3 and claudin-4 expression during
intestinal differentiation of gastric carcinoma. Pathol Int.
58:156–163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang H and Yang X: The expression patterns
of tight junction protein claudin-1, −3, and −4 in human gastric
neoplasms and adjacent non-neoplastic tissues. Int J Clin Exp
Pathol. 8:881–887. 2015.PubMed/NCBI
|
|
14
|
Jung H, Jun KH, Jung JH, Chin HM and Park
WB: The expression of claudin-1, claudin-2, claudin-3, and
claudin-4 in gastric cancer tissue. J Surg Res. 167:e185–e191.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okugawa T, Oshima T, Chen X, Hori K,
Tomita T, Fukui H, Watari J, Matsumoto T and Miwa H:
Down-regulation of claudin-3 is associated with proliferative
potential in early gastric cancers. Dig Dis Sci. 57:1562–1567.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsuda Y, Semba S, Ueda J, Fuku T, Hasuo
T, Chiba H, Sawada N, Kuroda Y and Yokozaki H: Gastric and
intestinal claudin expression at the invasive front of gastric
carcinoma. Cancer Sci. 98:1014–1019. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Auclair G and Weber M: Mechanisms of DNA
methylation and demethylation in mammals. Biochimie. 94:2202–2211.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hahn-Strömberg V, Askari S, Ahmad A,
Befekadu R and Nilsson TK: Expression of claudin 1, claudin 4, and
claudin 7 in colorectal cancer and its relation with CLDN DNA
methylation patterns. Tumour Biol. 39:10104283176975692017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Honda H, Pazin MJ, D'Souza T, Ji H and
Morin PJ: Regulation of the CLDN3 gene in ovarian cancer cells.
Cancer Biol Ther. 6:1733–1742. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang L, Yang YD, Fu L, Xu W, Liu D, Liang
Q, Zhang X, Xu L, Guan XY, Wu B, et al: CLDN3 inhibits cancer
aggressiveness via Wnt-EMT signaling and is a potential prognostic
biomarker for hepatocellular carcinoma. Oncotarget. 5:7663–7676.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Agarwal R, Mori Y, Cheng Y, Jin Z, Olaru
AV, Hamilton JP, David S, Selaru FM, Yang J, Abraham JM, et al:
Silencing of claudin-11 is associated with increased invasiveness
of gastric cancer cells. PLoS One. 4:e80022009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu S, Singh K, Mangray S, Tavares R, Noble
L, Resnick MB and Yakirevich E: Claudin expression in high-grade
invasive ductal carcinoma of the breast: Correlation with the
molecular subtype. Mod Pathol. 26:485–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
VanGuilder HD, Vrana KE and Freeman WM:
Twenty-five years of quantitative PCR for gene expression analysis.
Biotechniques. 44:619–626. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sonohara F, Inokawa Y, Hayashi M, Kodera Y
and Nomoto S: Epigenetic modulation associated with carcinogenesis
and prognosis of human gastric cancer. Oncol Lett. 13:3363–3368.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng H, Takahashi H, Murai Y, Cui Z,
Nomoto K, Miwa S, Tsuneyama K and Takano Y: Pathobiological
characteristics of intestinal and diffuse-type gastric carcinoma in
Japan: An immunostaining study on the tissue microarray. J Clin
Pathol. 60:273–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pinheiro Ddo R, Ferreira WA, Barros MB,
Araujo MD, Rodrigues-Antunes S and Borges Bdo N: Perspectives on
new biomarkers in gastric cancer: Diagnostic and prognostic
applications. World J Gastroenterol. 20:11574–11585. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ehrlich M and Lacey M: DNA hypomethylation
and hemimethylation in cancer. Adv Exp Med Biol. 754:31–56. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mroz EA and Rocco JW: The challenges of
tumor genetic diversity. Cancer. 123:917–927. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun S and Li P: HMPL: A pipeline for
identifying hemimethylation patterns by comparing two samples.
Cancer Inform. 14 Suppl 2:S235–S245. 2015.
|
